跳至主要内容
临床试验/CTRI/2011/08/001934
CTRI/2011/08/001934已完成未知

A pilot study to test and validate the applicability of a bio-analytical assay for betahistine in plasma obtained from healthy male subjects after administration of a single dose of the marketed betahistine 24 mg IR tablet - nil

Abbott Healthcare Products BV0 个研究点目标入组 8 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • �BMI 18 - 28 kg/m2

排除标准

  • ?Subjects who participated in a previous betahistine trial
  • ?Subjects who can not communicate reliable with the investigator
  • ?Subjects who are unlikely to co-operate with the requirements of the study

研究者

相似试验